8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Bilirubin in coronary artery disease: Cytotoxic or protective?

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Bilirubin has traditionally been considered a cytotoxic waste product. However, recent studies have shown bilirubin to have anti-oxidant, anti-inflammatory, vasodilatory, anti-apoptotic and anti-proliferative functions. These properties potentially confer bilirubin a new role of protection especially in coronary artery disease (CAD), which is a low grade inflammatory process exacerbated by oxidative stress. In fact, recent literature reports an inverse relationship between serum concentration of bilirubin and the presence of CAD. In this article, we review the current literature exploring the association between levels of bilirubin and risk of CAD. We conclude that current evidence is inconclusive regarding the protective effect of bilirubin on CAD. A causal relationship between low serum bilirubin level and increased risk of CAD is not currently established.

          Related collections

          Most cited references48

          • Record: found
          • Abstract: found
          • Article: not found

          Heme oxygenase-1: unleashing the protective properties of heme.

          Heme oxygenase (HO)-1 catabolizes heme into three products: carbon monoxide (CO), biliverdin (which is rapidly converted to bilirubin) and free iron (which leads to the induction of ferritin, an iron-binding protein). HO-1 serves as a "protective" gene by virtue of the anti-inflammatory, anti-apoptotic and anti-proliferative actions of one or more of these three products. Administration of CO, biliverdin, bilirubin or iron-binding compounds is protective in rodent disease models of ischemia-reperfusion injury, allograft and xenograft survival, intimal hyperplasia following balloon injury or as seen in chronic graft rejection and others. We suggest that the products of HO-1 action could be valuable therapeutic agents and speculate that HO-1 functions as a "therapeutic funnel", mediating the beneficial effects attributed to other molecules, such as interleukin-10 (IL-10), inducible nitric oxide synthase (NOS2; iNOS) and prostaglandins. This Review is the third in a series on the regulation of the immune system by metabolic pathways.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Biliverdin reductase: a major physiologic cytoprotectant.

            Bilirubin, an abundant pigment that causes jaundice, has long lacked any clear physiologic role. It arises from enzymatic reduction by biliverdin reductase of biliverdin, a product of heme oxygenase activity. Bilirubin is a potent antioxidant that we show can protect cells from a 10,000-fold excess of H2O2. We report that bilirubin is a major physiologic antioxidant cytoprotectant. Thus, cellular depletion of bilirubin by RNA interference markedly augments tissue levels of reactive oxygen species and causes apoptotic cell death. Depletion of glutathione, generally regarded as a physiologic antioxidant cytoprotectant, elicits lesser increases in reactive oxygen species and cell death. The potent physiologic antioxidant actions of bilirubin reflect an amplification cycle whereby bilirubin, acting as an antioxidant, is itself oxidized to biliverdin and then recycled by biliverdin reductase back to bilirubin. This redox cycle may constitute the principal physiologic function of bilirubin.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase.

                Bookmark

                Author and article information

                Journal
                World J Gastrointest Pharmacol Ther
                WJGPT
                World Journal of Gastrointestinal Pharmacology and Therapeutics
                Baishideng Publishing Group Inc
                2150-5349
                6 November 2016
                6 November 2016
                : 7
                : 4
                : 469-476
                Affiliations
                Nancy Gupta, Sachin Sule, Department of Medicine, Westchester Medical Center, New York Medical College, Valhalla, NY 10595, United States
                Tavankit Singh, Department of Medicine, Cleveland Clinic, Cleveland, OH 44195, United States
                Rahul Chaudhary, Department of Medicine, Sinai Hospital of Baltimore, Johns Hopkins University, Baltimore, MD 21218, United States
                Sushil K Garg, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, United States
                Gurprataap Singh Sandhu, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15260, United States
                Varun Mittal, Einstein Healthcare Network, Philadelphia, PA 19141, United States
                Rahul Gupta, Government Medical College, Amritsar, Punjab 143001, India
                Roxana Bodin, Division of Gastroenterology and Hepatobiliary Disease, New York Medical College, Valhalla, NY 10595, United States
                Author notes

                Author contributions: All authors contributed to the manuscript; Gupta N, Singh T and Chaudhary R have contributed equally for the paper.

                Correspondence to: Nancy Gupta, MD, Department of Medicine, Westchester Medical Center, New York Medical College, 40 Sunshine Cottage Rd, Valhalla, NY 10595, United States. drnancygupta87@ 123456gmail.com

                Telephone: +1-914-5361563 Fax: +1-914-4935827

                Article
                jWJGPT.v7.i4.pg469
                10.4292/wjgpt.v7.i4.469
                5095566
                48141286-af0c-4a2a-afc8-9bb94b8c1e2f
                ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.

                This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.

                History
                : 2 April 2016
                : 7 June 2016
                : 27 August 2016
                Categories
                Review

                bilirubin,cytotoxic,protective,anti-oxidant,anti-inflammatory,anti coronary artery disease,lipid peroxidation,gilbert

                Comments

                Comment on this article